nodes	percent_of_prediction	percent_of_DWPC	metapath
Risperidone—DRD4—Gilles de la Tourette syndrome	0.281	0.342	CbGaD
Risperidone—DRD3—Gilles de la Tourette syndrome	0.242	0.295	CbGaD
Risperidone—DRD2—Gilles de la Tourette syndrome	0.168	0.204	CbGaD
Risperidone—HTR2A—Gilles de la Tourette syndrome	0.13	0.158	CbGaD
Risperidone—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.0041	0.0875	CbGeAlD
Risperidone—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00255	0.0546	CbGeAlD
Risperidone—Paliperidone—DRD4—Gilles de la Tourette syndrome	0.00152	0.202	CrCbGaD
Risperidone—Paliperidone—DRD3—Gilles de la Tourette syndrome	0.00131	0.174	CrCbGaD
Risperidone—DRD4—brain—Gilles de la Tourette syndrome	0.00126	0.0269	CbGeAlD
Risperidone—DRD3—nervous system—Gilles de la Tourette syndrome	0.00116	0.0247	CbGeAlD
Risperidone—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00112	0.0238	CbGeAlD
Risperidone—Iloperidone—DRD4—Gilles de la Tourette syndrome	0.00106	0.141	CrCbGaD
Risperidone—H1F0—midbrain—Gilles de la Tourette syndrome	0.00102	0.0218	CbGeAlD
Risperidone—DRD1—midbrain—Gilles de la Tourette syndrome	0.00101	0.0216	CbGeAlD
Risperidone—Iloperidone—DRD3—Gilles de la Tourette syndrome	0.000917	0.122	CrCbGaD
Risperidone—Paliperidone—DRD2—Gilles de la Tourette syndrome	0.000907	0.12	CrCbGaD
Risperidone—ADRA1B—nervous system—Gilles de la Tourette syndrome	0.00089	0.019	CbGeAlD
Risperidone—DRD3—brain—Gilles de la Tourette syndrome	0.000885	0.0189	CbGeAlD
Risperidone—ADRA1B—central nervous system—Gilles de la Tourette syndrome	0.000857	0.0183	CbGeAlD
Risperidone—H1F0—nervous system—Gilles de la Tourette syndrome	0.00084	0.0179	CbGeAlD
Risperidone—DRD1—nervous system—Gilles de la Tourette syndrome	0.000829	0.0177	CbGeAlD
Risperidone—HTR1B—midbrain—Gilles de la Tourette syndrome	0.000817	0.0175	CbGeAlD
Risperidone—H1F0—central nervous system—Gilles de la Tourette syndrome	0.000809	0.0173	CbGeAlD
Risperidone—DRD1—central nervous system—Gilles de la Tourette syndrome	0.000798	0.0171	CbGeAlD
Risperidone—HTR1D—midbrain—Gilles de la Tourette syndrome	0.000791	0.0169	CbGeAlD
Risperidone—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000784	0.0167	CbGeAlD
Risperidone—Paliperidone—HTR2A—Gilles de la Tourette syndrome	0.000701	0.0929	CrCbGaD
Risperidone—ADRA1B—brain—Gilles de la Tourette syndrome	0.00068	0.0145	CbGeAlD
Risperidone—HTR1B—nervous system—Gilles de la Tourette syndrome	0.000672	0.0144	CbGeAlD
Risperidone—HTR1A—midbrain—Gilles de la Tourette syndrome	0.00066	0.0141	CbGeAlD
Risperidone—HTR1D—nervous system—Gilles de la Tourette syndrome	0.000651	0.0139	CbGeAlD
Risperidone—HTR1B—central nervous system—Gilles de la Tourette syndrome	0.000647	0.0138	CbGeAlD
Risperidone—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000644	0.0138	CbGeAlD
Risperidone—H1F0—brain—Gilles de la Tourette syndrome	0.000642	0.0137	CbGeAlD
Risperidone—Iloperidone—DRD2—Gilles de la Tourette syndrome	0.000634	0.0841	CrCbGaD
Risperidone—DRD1—brain—Gilles de la Tourette syndrome	0.000634	0.0135	CbGeAlD
Risperidone—HTR7—midbrain—Gilles de la Tourette syndrome	0.00063	0.0135	CbGeAlD
Risperidone—HTR1D—central nervous system—Gilles de la Tourette syndrome	0.000626	0.0134	CbGeAlD
Risperidone—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.00062	0.0133	CbGeAlD
Risperidone—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000605	0.0129	CbGeAlD
Risperidone—DRD2—midbrain—Gilles de la Tourette syndrome	0.000596	0.0127	CbGeAlD
Risperidone—KCNH2—midbrain—Gilles de la Tourette syndrome	0.000587	0.0125	CbGeAlD
Risperidone—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000583	0.0124	CbGeAlD
Risperidone—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000579	0.0124	CbGeAlD
Risperidone—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000542	0.0116	CbGeAlD
Risperidone—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000522	0.0112	CbGeAlD
Risperidone—HTR7—nervous system—Gilles de la Tourette syndrome	0.000518	0.0111	CbGeAlD
Risperidone—HTR1B—brain—Gilles de la Tourette syndrome	0.000514	0.011	CbGeAlD
Risperidone—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.0005	0.0107	CbGeAlD
Risperidone—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000499	0.0107	CbGeAlD
Risperidone—HTR1D—brain—Gilles de la Tourette syndrome	0.000497	0.0106	CbGeAlD
Risperidone—HTR2C—brain—Gilles de la Tourette syndrome	0.000492	0.0105	CbGeAlD
Risperidone—Iloperidone—HTR2A—Gilles de la Tourette syndrome	0.00049	0.065	CrCbGaD
Risperidone—DRD2—nervous system—Gilles de la Tourette syndrome	0.00049	0.0105	CbGeAlD
Risperidone—KCNH2—nervous system—Gilles de la Tourette syndrome	0.000483	0.0103	CbGeAlD
Risperidone—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000481	0.0103	CbGeAlD
Risperidone—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000476	0.0102	CbGeAlD
Risperidone—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000472	0.0101	CbGeAlD
Risperidone—KCNH2—central nervous system—Gilles de la Tourette syndrome	0.000465	0.00993	CbGeAlD
Risperidone—HTR2B—brain—Gilles de la Tourette syndrome	0.000463	0.00988	CbGeAlD
Risperidone—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000462	0.00988	CbGeAlD
Risperidone—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000459	0.0098	CbGeAlD
Risperidone—HTR1A—brain—Gilles de la Tourette syndrome	0.000414	0.00886	CbGeAlD
Risperidone—HTR7—brain—Gilles de la Tourette syndrome	0.000396	0.00846	CbGeAlD
Risperidone—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000393	0.0084	CbGeAlD
Risperidone—HRH1—nervous system—Gilles de la Tourette syndrome	0.000387	0.00827	CbGeAlD
Risperidone—ADRA1A—brain—Gilles de la Tourette syndrome	0.000382	0.00816	CbGeAlD
Risperidone—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.00038	0.00812	CbGeAlD
Risperidone—DRD2—brain—Gilles de la Tourette syndrome	0.000374	0.008	CbGeAlD
Risperidone—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000373	0.00796	CbGeAlD
Risperidone—KCNH2—brain—Gilles de la Tourette syndrome	0.000369	0.00788	CbGeAlD
Risperidone—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000366	0.00782	CbGeAlD
Risperidone—ADRA2C—brain—Gilles de la Tourette syndrome	0.000364	0.00778	CbGeAlD
Risperidone—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000323	0.00691	CbGeAlD
Risperidone—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000311	0.00665	CbGeAlD
Risperidone—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000299	0.00639	CbGeAlD
Risperidone—HRH1—brain—Gilles de la Tourette syndrome	0.000296	0.00632	CbGeAlD
Risperidone—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000294	0.00629	CbGeAlD
Risperidone—ADRA2A—brain—Gilles de la Tourette syndrome	0.00029	0.00621	CbGeAlD
Risperidone—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000288	0.00615	CbGeAlD
Risperidone—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000283	0.00606	CbGeAlD
Risperidone—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000258	0.0055	CbGeAlD
Risperidone—HTR2A—brain—Gilles de la Tourette syndrome	0.000247	0.00528	CbGeAlD
Risperidone—CYP2D6—brain—Gilles de la Tourette syndrome	0.000225	0.00481	CbGeAlD
Risperidone—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000212	0.00453	CbGeAlD
Risperidone—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000204	0.00436	CbGeAlD
Risperidone—ABCB1—brain—Gilles de la Tourette syndrome	0.000162	0.00346	CbGeAlD
Risperidone—ADRA2B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.76e-05	0.000463	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.74e-05	0.000461	CbGpPWpGaD
Risperidone—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	5.71e-05	0.000459	CbGpPWpGaD
Risperidone—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.69e-05	0.000457	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.69e-05	0.000457	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.56e-05	0.000447	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.53e-05	0.000445	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.4e-05	0.000434	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.38e-05	0.000433	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.31e-05	0.000427	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.3e-05	0.000426	CbGpPWpGaD
Risperidone—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.3e-05	0.000426	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.3e-05	0.000426	CbGpPWpGaD
Risperidone—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.26e-05	0.000423	CbGpPWpGaD
Risperidone—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.24e-05	0.000421	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.24e-05	0.000421	CbGpPWpGaD
Risperidone—HTR1D—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.22e-05	0.00042	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.2e-05	0.000418	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.16e-05	0.000415	CbGpPWpGaD
Risperidone—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.15e-05	0.000414	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.15e-05	0.000414	CbGpPWpGaD
Risperidone—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.12e-05	0.000411	CbGpPWpGaD
Risperidone—HTR1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.11e-05	0.000411	CbGpPWpGaD
Risperidone—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.000409	CbGpPWpGaD
Risperidone—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.05e-05	0.000406	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.05e-05	0.000406	CbGpPWpGaD
Risperidone—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.03e-05	0.000404	CbGpPWpGaD
Risperidone—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.95e-05	0.000398	CbGpPWpGaD
Risperidone—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.87e-05	0.000392	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.83e-05	0.000389	CbGpPWpGaD
Risperidone—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.81e-05	0.000386	CbGpPWpGaD
Risperidone—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.8e-05	0.000386	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.8e-05	0.000385	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.71e-05	0.000378	CbGpPWpGaD
Risperidone—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.69e-05	0.000377	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.69e-05	0.000377	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.69e-05	0.000377	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.66e-05	0.000375	CbGpPWpGaD
Risperidone—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.64e-05	0.000373	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.56e-05	0.000367	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.55e-05	0.000366	CbGpPWpGaD
Risperidone—DRD1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.53e-05	0.000364	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.52e-05	0.000364	CbGpPWpGaD
Risperidone—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.49e-05	0.000361	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.49e-05	0.000361	CbGpPWpGaD
Risperidone—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.47e-05	0.000359	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.43e-05	0.000356	CbGpPWpGaD
Risperidone—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.41e-05	0.000354	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.37e-05	0.000351	CbGpPWpGaD
Risperidone—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.33e-05	0.000348	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.29e-05	0.000344	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.26e-05	0.000342	CbGpPWpGaD
Risperidone—CYP3A5—Metabolism—HDC—Gilles de la Tourette syndrome	4.25e-05	0.000341	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.24e-05	0.000341	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.23e-05	0.00034	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.21e-05	0.000339	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.16e-05	0.000334	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.14e-05	0.000333	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.14e-05	0.000332	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.13e-05	0.000332	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.11e-05	0.00033	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.08e-05	0.000328	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.06e-05	0.000326	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.04e-05	0.000325	CbGpPWpGaD
Risperidone—ADRA2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.04e-05	0.000324	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.02e-05	0.000323	CbGpPWpGaD
Risperidone—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.02e-05	0.000323	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.92e-05	0.000315	CbGpPWpGaD
Risperidone—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.9e-05	0.000313	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.89e-05	0.000313	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.88e-05	0.000312	CbGpPWpGaD
Risperidone—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.88e-05	0.000311	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.87e-05	0.000311	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.85e-05	0.00031	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.83e-05	0.000308	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.78e-05	0.000304	CbGpPWpGaD
Risperidone—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.77e-05	0.000303	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.75e-05	0.000301	CbGpPWpGaD
Risperidone—ADRA1B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.71e-05	0.000298	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.69e-05	0.000296	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.67e-05	0.000295	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.66e-05	0.000294	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.61e-05	0.00029	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.6e-05	0.000289	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.56e-05	0.000286	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.52e-05	0.000283	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.52e-05	0.000283	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.5e-05	0.000281	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.48e-05	0.000279	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.46e-05	0.000278	CbGpPWpGaD
Risperidone—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.42e-05	0.000275	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.37e-05	0.000271	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.36e-05	0.00027	CbGpPWpGaD
Risperidone—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.36e-05	0.00027	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.36e-05	0.00027	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.32e-05	0.000267	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.31e-05	0.000266	CbGpPWpGaD
Risperidone—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.3e-05	0.000265	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.28e-05	0.000263	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.27e-05	0.000263	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.27e-05	0.000262	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.26e-05	0.000262	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.21e-05	0.000258	CbGpPWpGaD
Risperidone—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	3.21e-05	0.000258	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.17e-05	0.000255	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.16e-05	0.000254	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.14e-05	0.000253	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.14e-05	0.000252	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.13e-05	0.000251	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.06e-05	0.000246	CbGpPWpGaD
Risperidone—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.06e-05	0.000246	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.05e-05	0.000245	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.05e-05	0.000245	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.05e-05	0.000245	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.04e-05	0.000244	CbGpPWpGaD
Risperidone—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	3.02e-05	0.000243	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.01e-05	0.000242	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3e-05	0.000241	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3e-05	0.000241	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.99e-05	0.000241	CbGpPWpGaD
Risperidone—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.97e-05	0.000239	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.97e-05	0.000238	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.96e-05	0.000238	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.96e-05	0.000238	CbGpPWpGaD
Risperidone—HTR1D—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.95e-05	0.000237	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.94e-05	0.000236	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.92e-05	0.000235	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.92e-05	0.000234	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.91e-05	0.000234	CbGpPWpGaD
Risperidone—HTR1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.89e-05	0.000232	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.85e-05	0.000229	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.85e-05	0.000229	CbGpPWpGaD
Risperidone—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.84e-05	0.000229	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.84e-05	0.000228	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.77e-05	0.000223	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.76e-05	0.000222	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.73e-05	0.00022	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.73e-05	0.000219	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.72e-05	0.000219	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.72e-05	0.000218	CbGpPWpGaD
Risperidone—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.72e-05	0.000218	CbGpPWpGaD
Risperidone—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.72e-05	0.000218	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.71e-05	0.000218	CbGpPWpGaD
Risperidone—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.7e-05	0.000217	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.69e-05	0.000216	CbGpPWpGaD
Risperidone—HTR1D—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000215	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.67e-05	0.000215	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.66e-05	0.000214	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.65e-05	0.000213	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.65e-05	0.000213	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.64e-05	0.000212	CbGpPWpGaD
Risperidone—HTR1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.62e-05	0.000211	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.59e-05	0.000208	CbGpPWpGaD
Risperidone—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.58e-05	0.000208	CbGpPWpGaD
Risperidone—DRD1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.56e-05	0.000206	CbGpPWpGaD
Risperidone—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.53e-05	0.000203	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.52e-05	0.000202	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.5e-05	0.000201	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.48e-05	0.000199	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.47e-05	0.000199	CbGpPWpGaD
Risperidone—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.47e-05	0.000198	CbGpPWpGaD
Risperidone—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.47e-05	0.000198	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.46e-05	0.000198	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000197	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.44e-05	0.000196	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.43e-05	0.000195	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.41e-05	0.000194	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.41e-05	0.000194	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.41e-05	0.000194	CbGpPWpGaD
Risperidone—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	2.38e-05	0.000191	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000191	CbGpPWpGaD
Risperidone—DRD1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.33e-05	0.000187	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.3e-05	0.000185	CbGpPWpGaD
Risperidone—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.29e-05	0.000184	CbGpPWpGaD
Risperidone—ADRA2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000183	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.28e-05	0.000183	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.26e-05	0.000182	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.24e-05	0.00018	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.23e-05	0.000179	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.21e-05	0.000178	CbGpPWpGaD
Risperidone—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.2e-05	0.000177	CbGpPWpGaD
Risperidone—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.19e-05	0.000176	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.18e-05	0.000175	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.17e-05	0.000174	CbGpPWpGaD
Risperidone—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.13e-05	0.000171	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.11e-05	0.000169	CbGpPWpGaD
Risperidone—ADRA1B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.1e-05	0.000169	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.08e-05	0.000167	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.08e-05	0.000167	CbGpPWpGaD
Risperidone—ADRA2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000166	CbGpPWpGaD
Risperidone—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2e-05	0.000161	CbGpPWpGaD
Risperidone—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.99e-05	0.00016	CbGpPWpGaD
Risperidone—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.97e-05	0.000159	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.96e-05	0.000158	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.94e-05	0.000156	CbGpPWpGaD
Risperidone—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.000155	CbGpPWpGaD
Risperidone—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.93e-05	0.000155	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.93e-05	0.000155	CbGpPWpGaD
Risperidone—ADRA1B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.000153	CbGpPWpGaD
Risperidone—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.9e-05	0.000153	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.88e-05	0.000151	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.00015	CbGpPWpGaD
Risperidone—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.86e-05	0.00015	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.86e-05	0.000149	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.81e-05	0.000145	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.8e-05	0.000145	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.8e-05	0.000145	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.78e-05	0.000143	CbGpPWpGaD
Risperidone—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.76e-05	0.000141	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.75e-05	0.000141	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.75e-05	0.00014	CbGpPWpGaD
Risperidone—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.73e-05	0.000139	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.72e-05	0.000139	CbGpPWpGaD
Risperidone—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.72e-05	0.000139	CbGpPWpGaD
Risperidone—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.69e-05	0.000136	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.69e-05	0.000136	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.68e-05	0.000135	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.64e-05	0.000132	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.63e-05	0.000131	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.61e-05	0.000129	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.61e-05	0.000129	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.61e-05	0.000129	CbGpPWpGaD
Risperidone—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.59e-05	0.000128	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.59e-05	0.000128	CbGpPWpGaD
Risperidone—HTR1D—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.58e-05	0.000127	CbGpPWpGaD
Risperidone—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.57e-05	0.000126	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000126	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.56e-05	0.000125	CbGpPWpGaD
Risperidone—HTR1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.000125	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.53e-05	0.000123	CbGpPWpGaD
Risperidone—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.53e-05	0.000123	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.47e-05	0.000118	CbGpPWpGaD
Risperidone—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.46e-05	0.000117	CbGpPWpGaD
Risperidone—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.46e-05	0.000117	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.45e-05	0.000117	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.43e-05	0.000115	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.42e-05	0.000114	CbGpPWpGaD
Risperidone—DRD1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.37e-05	0.00011	CbGpPWpGaD
Risperidone—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.36e-05	0.000109	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.33e-05	0.000107	CbGpPWpGaD
Risperidone—ADRA2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.22e-05	9.83e-05	CbGpPWpGaD
Risperidone—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.18e-05	9.49e-05	CbGpPWpGaD
Risperidone—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.18e-05	9.44e-05	CbGpPWpGaD
Risperidone—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.14e-05	9.18e-05	CbGpPWpGaD
Risperidone—ADRA1B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.12e-05	9.04e-05	CbGpPWpGaD
Risperidone—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.04e-05	8.33e-05	CbGpPWpGaD
Risperidone—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.02e-05	8.18e-05	CbGpPWpGaD
Risperidone—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.99e-06	8.03e-05	CbGpPWpGaD
Risperidone—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.28e-06	7.46e-05	CbGpPWpGaD
